FLOT1 and multiple sclerosis: We have identified six patients with autoantibodies against the FLOT-1/2 complex and one patient with autoantibodies against ANO2 protein in a study to screen for the presence of antibodies against NF155, ANO2 and FLOT1/2, previously described as multiple sclerosis antigens.